HIV/AIDS
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male at birth, and had sex with male sexual partners; 2. Aged 18-65 years old; 3. Subjects who reported one or more of the following risk criteria in the last 6 months: (1) Had unprotected receptive anal sex with a male partner; (2) Had more than 2 male sexual partners; (3) Self-reported sexually transmitted infections (STIs) including syphilis, gonorrhea, chlamydia, chancroid or lymphogranuloma; (4) used post-exposure prophylaxis (PEP) medication, but did not receive PEP in the last 1 month; Note: Subjects who maintain a >1 year single sexual relationship with only one HIV-1 seronegative partner or a virologically suppressed HIV-1+ partner may not participate in the study. 5. At screening, the fourth generation HIV test result should be non-reactive and the HIV-1 RNA should be undetectable; 6. After a comprehensive physical examination (including general physical examination, hematuria, blood biochemical examination, etc.) without serious liver and kidney dysfunction and other indicators in the basic normal range; 7. Those who are informed of the study protocol and who agree to participate in the study and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: Those who are unwilling to sign informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HIV self-testing frequency;the occurence of high risk sexual behaviors;recent infection rate of syphilis or HSV-2; | — |
Secondary
| Measure | Time frame |
|---|---|
| STIs treatment adherence; | — |
Countries
China
Contacts
NHC Key Laboratory of AIDS Immunology (China Medical University), Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China